Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Public ClinicalTrials.gov record NCT02711826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Treg Adoptive Therapy in Subclinical Inflammation in Kidney Transplantation (CTOT-21)
Study identification
- NCT ID
- NCT02711826
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 32 participants
Conditions and interventions
Conditions
Interventions
- Polyclonal Regulatory T Cells Biological
- Everolimus Drug
- Tacrolimus Drug
- Mycophenolate mofetil Drug
- Mycophenolic acid Drug
- Acetaminophen Drug
- Diphenhydramine Drug
- Biopsy, Kidney Procedure
- Blood Draw Procedure
- Leukapheresis Procedure
- IS regimen conversion Procedure
Biological · Drug · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 19, 2016
- Primary completion
- Aug 3, 2023
- Completion
- Aug 3, 2023
- Last update posted
- Apr 8, 2025
2016 – 2023
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama, Birmingham | Birmingham | Alabama | 35294 | — |
| University of California at San Francisco | San Francisco | California | 94118 | — |
| University of Colorado Health Transplant Center - Anschutz | Aurora | Colorado | 80045 | — |
| Northwestern University Comprehensive Transplant Center | Chicago | Illinois | 60611 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02711826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02711826 live on ClinicalTrials.gov.